ArticleEmerging infectious diseases2025

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.

Valentina Gerussi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.